132 related articles for article (PubMed ID: 6549355)
1. Ludwig Breast Cancer trials LBCS III and IV: adjuvant endocrine treatment in postmenopausal patients.
Goldhirsch A
Recent Results Cancer Res; 1984; 96():204-9. PubMed ID: 6549355
[No Abstract] [Full Text] [Related]
2. Ludwig Breast Cancer trial LBCS III: chemo- and endocrine adjuvant treatment in postmenopausal patients.
Gelber RD
Recent Results Cancer Res; 1984; 96():102-9. PubMed ID: 6396763
[No Abstract] [Full Text] [Related]
3. Adjuvant chemo-endocrine therapy or endocrine therapy alone for postmenopausal patients: Ludwig Studies III and IV.
Goldhirsch A; Gelber RD
Recent Results Cancer Res; 1989; 115():153-62. PubMed ID: 2696027
[No Abstract] [Full Text] [Related]
4. Chemo- or endocrine adjuvant therapy alone or combined in postmenopausal patients (GABG Trial 1).
Jonat W; Kaufmann M; Abel U
Recent Results Cancer Res; 1989; 115():163-9. PubMed ID: 2696028
[No Abstract] [Full Text] [Related]
5. Hormone receptors. An update and application.
Hubay CA; Arafah B; Gordon NH; Guyton SP; Crowe JP
Surg Clin North Am; 1984 Dec; 64(6):1155-72. PubMed ID: 6393400
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant systemic therapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group's trials of cyclophosphamide or CMF in premenopausal and tamoxifen in postmenopausal patients.
Mouridsen HT; Rose C; Brincker H; Thorpe SM; Rank F; Fischerman K; Andersen KW
Recent Results Cancer Res; 1984; 96():117-28. PubMed ID: 6396765
[No Abstract] [Full Text] [Related]
7. Tamoxifen and combination chemotherapy as adjuvant treatment in postmenopausal women with breast cancer.
Wallgren A; Baral E; Beling U; Carstensen J; Friberg S; Glas U; Kaigas M; Skoog L
Recent Results Cancer Res; 1984; 96():197-203. PubMed ID: 6396775
[No Abstract] [Full Text] [Related]
8. Randomised trial of chemo-endocrine therapy, endocrine therapy, and mastectomy alone in postmenopausal patients with operable breast cancer and axillary node metastasis.
Ludwig Breast Cancer Study Group
Lancet; 1984 Jun; 1(8389):1256-60. PubMed ID: 6144974
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant CMFP versus CMFP plus tamoxifen versus observation alone in postmenopausal, node-positive breast cancer patients: three-year results of an Eastern Cooperative Oncology Group study.
Taylor SG; Kalish LA; Olson JE; Cummings F; Bennett JM; Falkson G; Tormey DC; Carbone PP
J Clin Oncol; 1985 Feb; 3(2):144-54. PubMed ID: 3881561
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant programs for postmenopausal women with node-positive breast cancer: preliminary analysis of 5-year results.
Rossi A; Brambilla C; Valagussa P; Bonadonna G
Recent Results Cancer Res; 1984; 96():178-83. PubMed ID: 6396772
[No Abstract] [Full Text] [Related]
11. Adjuvant therapy of breast cancer: a Southwest Oncology Group experience.
Rivkin SE; Glucksberg H; Foulkes M
Recent Results Cancer Res; 1984; 96():166-74. PubMed ID: 6396770
[No Abstract] [Full Text] [Related]
12. Adjuvant systemic therapy in postoperative node-positive patients with breast carcinoma: the CALGB trial and the ECOG premenopausal trial.
Tormey C
Recent Results Cancer Res; 1984; 96():155-65. PubMed ID: 6396769
[No Abstract] [Full Text] [Related]
13. Adjuvant systemic therapy in primary breast cancer.
Mouridsen HT; Palshof T
Acta Chir Scand Suppl; 1984; 519():43-53. PubMed ID: 6393664
[No Abstract] [Full Text] [Related]
14. Adjuvant treatment in operable breast cancer.
Goldhirsch A
J Steroid Biochem; 1985 Dec; 23(6B):1155-60. PubMed ID: 3912622
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant treatment for early breast cancer: the Ludwig breast cancer studies.
Goldhirsch A; Gelber R
NCI Monogr; 1986; (1):55-70. PubMed ID: 3774016
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant chemotherapy of breast cancer: a promising experiment or standard practice?
Henderson IC
J Clin Oncol; 1985 Feb; 3(2):140-3. PubMed ID: 3881560
[No Abstract] [Full Text] [Related]
17. Endocrine versus endocrine plus five-drug chemotherapy in postmenopausal women with stage II estrogen receptor-positive breast cancer.
Pearson OH; Hubay CA; Gordon NH; Marshall JS; Crowe JP; Arafah BM; McGuire W
Cancer; 1989 Nov; 64(9):1819-23. PubMed ID: 2790695
[TBL] [Abstract][Full Text] [Related]
18. A new endpoint for the assessment of adjuvant therapy in postmenopausal women with operable breast cancer.
Gelber RD; Goldhirsch A
J Clin Oncol; 1986 Dec; 4(12):1772-9. PubMed ID: 3783203
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant systemic therapy for resectable breast cancer.
Bonadonna G; Valagussa P
J Clin Oncol; 1985 Feb; 3(2):259-75. PubMed ID: 3881562
[No Abstract] [Full Text] [Related]
20. Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer. An intergroup study.
Mansour EG; Gray R; Shatila AH; Osborne CK; Tormey DC; Gilchrist KW; Cooper MR; Falkson G
N Engl J Med; 1989 Feb; 320(8):485-90. PubMed ID: 2915651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
